Project Details
Description
A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)
| Status | Active |
|---|---|
| Effective start/end date | 9/22/22 → 9/30/27 |
Funding
- RHEACELL GMBH & CO KG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.